United States - English - NLM (National Library of Medicine)

puracap laboratories llc dba blu pharmaceuticals - rosuvastatin calcium (unii: 83mvu38m7q) (rosuvastatin - unii:413kh5zj73) - rosuvastatin tablets are indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. rosuvastatin tablets are indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (type iii hyperlipoproteinemia). rosuvastatin tablets are indicated as adjunctive therapy to other lipid-lowering treatments (e.g., ldl apheresis) or alone if such treatments are unavailable to reduce ldl-c, total-c, and apob in adult patients with homozygous familial hypercholesterolemia. rosuvastatin tablets have not been studied in fredrickson type i and v dyslipidemias. rosuvastatin tablets are contraindicated in the following conditions: risk summary rosuvastatin is contraindicated for use in pregnant women since safety in pregnant women has not been established and there is no apparent benefit to therapy with rosuvastatin during pregnancy. because hmg-coa reductase inhibitors decrease cholesterol synthesis and possibly the synthesis of other biologica

United States - English - NLM (National Library of Medicine)

puracap laboratories llc dba blu pharmaceuticals - aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - aminocaproic acid is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. in life- threatening situations, transfusion of appropriate blood products and other emergency measures may be required. fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures) and portacaval shunt; hematological disorders such as amegakaryocytic thrombocytopenia (accompanying aplastic anemia); acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. urinary fibrinolysis, usualiy a normal physiological phenomenon, may contribute to excessive urinary tract fibrinolytic bleeding associated with surgical hematuria (following prostatectomy and nephrectomy) or nonsurgical hematuria (accompanying polycystic or neoplastic diseases of the genitourinary system). (see warnings. ) aminocaproic acid should not be used when there is evidence of an

United States - English - NLM (National Library of Medicine)

puracap laboratories llc - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 360 mg - diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive medications. diltiazem hydrochloride extended-release capsules are indicated for the treatment of chronic stable angina. diltiazem is contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree av block except in the presence of a functioning ventricular pacemaker, (3) patients with severe hypotension (less than 90 mm hg systolic),(4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission.

United States - English - NLM (National Library of Medicine)

puracap laboratories llc - demeclocycline hydrochloride (unii: 29o079ntyt) (demeclocycline - unii:5r5w9ici6o) - demeclocycline hydrochloride 150 mg - demeclocycline hydrochloride tablets usp is indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions below: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae; respiratory tract infections caused by mycoplasma pneumoniae ; lymphogranuloma venereum due to chlamydia trachomatis ; psittacosis (ornithosis) due to chlamydia psittaci ; trachoma due to chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence; inclusion conjunctivitis caused by chlamydia trachomatis ; nongonococcal urethritis in adults caused by ureaplasma urealyticum or chlamydia trachomatis ; relapsing fever due to borrelia recurrentis ; chancroid caused by haemophilus ducreyi ; plague due to yersinia pestis ; tu

United States - English - NLM (National Library of Medicine)

puracap laboratories, llc - simvastatin (unii: agg2fn16ev) (simvastatin - unii:agg2fn16ev) - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with coronary heart disease (chd) or at high risk of chd, simvastatin can be started simultaneously with diet. in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease, simvastatin is indicated to: •    reduce the risk of total mortality by reducing chd deaths. •    reduce the risk of non-fatal myocardial infarction and stroke. •    reduce the need for coronary and non-coronary revascularization procedures. simvastatin is indicated to: •    reduce elevated total cholesterol (total-c), low-de

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms: because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline is indicated for treatment of infections caused by the following gram-negative bacteria, when bacteriologic testing in

United States - English - NLM (National Library of Medicine)

puracap pharmaceutical, llc - gemfibrozil (unii: q8x02027x3) (gemfibrozil - unii:q8x02027x3) - gemfibrozil tablets, usp are indicated as adjunctive therapy to diet for: 1. treatment of adult patients with very high elevations of serum triglyceride levels (types iv and v hyperlipidemia) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them. patients who present such risk typically have serum triglycerides over 2000 mg/dl and have elevations of vldl-cholesterol as well as fasting chylomicrons (type v hyperlipidemia). subjects who consistently have total serum or plasma triglycerides below 1000 mg/dl are unlikely to present a risk of pancreatitis. gemfibrozil therapy may be considered for those subjects with triglyceride elevations between 1000 and 2000 mg/dl who have a history of pancreatitis or of recurrent abdominal pain typical of pancreatitis. it is recognized that some type iv patients with triglycerides under 1000 mg/dl may, through dietary or alcoholic indiscretion, convert to a type v pattern with massive triglyceride elevations accomp

United States - English - NLM (National Library of Medicine)

puracap pharmaceutical llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - acetaminophen 325 mg - daytime severe cold and flu pain reliever/fever reducer cough suppressant expectorant nasal decongestant nighttime severe cold and flu pain reliever/fever reducer cough suppressant antihistamine nasal decongestant daytime severe cold and flu relief - temporarily relieves common cold/flu symptoms: - nasal congestion - sinus congestion & pressure - cough due to minor throat & bronchial irritation - minor aches & pains - headache - fever - sore throat - reduces swelling of nasal passages - temporarily restores freer breathing through the nose - promotes nasal and/or sinus drainage - helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive nighttime severe cold and flu relief - temporarily relieves common cold/flu symptoms: - nasal congestion - sinus congestion & pressure - cough due to minor throat & bronchial irritation - cough to help you sleep - minor aches & pains - headache - fever - sore throat - runny nose & sneezing - r

United States - English - NLM (National Library of Medicine)

puracap pharmaceutical llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), doxylamine succinate (unii: v9bi9b5yi2) (doxylamine - unii:95qb77jkpl), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - acetaminophen 325 mg - pain reliever/fever reducer cough suppressant antihistamine nasal decongestant - temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: - runny nose - sneezing - itching of the nose or throat - itchy, watery eyes - temporarily relieves these symptoms due to a cold: - nasal congestion - sinus congestion and pressure - headache - minor aches and pains - cough - temporarily reduces fever

United States - English - NLM (National Library of Medicine)

puracap pharmaceutical llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - acetaminophen 325 mg - dg day time cold & flu formula pain reliever/fever reducer cough suppressant nasal decongestant dg night time cold & flu formula pain reliever/fever reducer cough suppressant antihistamine nasal decongestant - temporarily relieves these symptoms due to a cold or flu: minor aches and pains headache nasal and sinus congestion cough sore throat runny nose and sneezing (night time only) - minor aches and pains - headache - nasal and sinus congestion - cough - sore throat - runny nose and sneezing (night time only) - temporarily reduces fever